nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA9—breast cancer	0.323	0.776	CbGaD
Dorzolamide—CYP3A4—breast cancer	0.093	0.224	CbGaD
Dorzolamide—CYP2C9—Anastrozole—breast cancer	0.0333	0.114	CbGbCtD
Dorzolamide—CYP3A4—Exemestane—breast cancer	0.0256	0.0873	CbGbCtD
Dorzolamide—CYP2C9—Idarubicin—breast cancer	0.0252	0.0862	CbGbCtD
Dorzolamide—CYP3A4—Letrozole—breast cancer	0.0217	0.0742	CbGbCtD
Dorzolamide—CYP3A4—Anastrozole—breast cancer	0.0194	0.0662	CbGbCtD
Dorzolamide—CYP3A4—Toremifene—breast cancer	0.0177	0.0605	CbGbCtD
Dorzolamide—CYP3A4—Fulvestrant—breast cancer	0.0165	0.0563	CbGbCtD
Dorzolamide—CYP3A4—Thiotepa—breast cancer	0.0147	0.0501	CbGbCtD
Dorzolamide—CYP2C9—Capecitabine—breast cancer	0.0138	0.0472	CbGbCtD
Dorzolamide—CYP3A4—Ixabepilone—breast cancer	0.0134	0.0459	CbGbCtD
Dorzolamide—CYP3A4—Lapatinib—breast cancer	0.0129	0.0441	CbGbCtD
Dorzolamide—CYP2C9—Tamoxifen—breast cancer	0.0111	0.038	CbGbCtD
Dorzolamide—CYP3A4—Raloxifene—breast cancer	0.00979	0.0335	CbGbCtD
Dorzolamide—CYP2C9—Paclitaxel—breast cancer	0.00866	0.0296	CbGbCtD
Dorzolamide—CYP2C9—Fluorouracil—breast cancer	0.0082	0.028	CbGbCtD
Dorzolamide—CYP3A4—Vinorelbine—breast cancer	0.00717	0.0245	CbGbCtD
Dorzolamide—CYP3A4—Tamoxifen—breast cancer	0.00647	0.0221	CbGbCtD
Dorzolamide—CYP3A4—Mitoxantrone—breast cancer	0.00631	0.0216	CbGbCtD
Dorzolamide—CYP3A4—Paclitaxel—breast cancer	0.00504	0.0172	CbGbCtD
Dorzolamide—CYP3A4—Irinotecan—breast cancer	0.00497	0.017	CbGbCtD
Dorzolamide—CYP3A4—Vinblastine—breast cancer	0.00442	0.0151	CbGbCtD
Dorzolamide—CYP3A4—Docetaxel—breast cancer	0.00364	0.0124	CbGbCtD
Dorzolamide—Brinzolamide—CA9—breast cancer	0.00282	0.776	CrCbGaD
Dorzolamide—CYP3A4—Doxorubicin—breast cancer	0.00271	0.00927	CbGbCtD
Dorzolamide—CA5A—female reproductive system—breast cancer	0.00135	0.0662	CbGeAlD
Dorzolamide—CA5B—mammary gland—breast cancer	0.00127	0.062	CbGeAlD
Dorzolamide—CA5A—endocrine gland—breast cancer	0.00114	0.056	CbGeAlD
Dorzolamide—Brinzolamide—CYP3A4—breast cancer	0.000813	0.224	CrCbGaD
Dorzolamide—CA9—female reproductive system—breast cancer	0.000789	0.0387	CbGeAlD
Dorzolamide—CA14—adrenal gland—breast cancer	0.00073	0.0358	CbGeAlD
Dorzolamide—CA4—nipple—breast cancer	0.000722	0.0354	CbGeAlD
Dorzolamide—CA9—endocrine gland—breast cancer	0.000667	0.0327	CbGeAlD
Dorzolamide—CYP2C9—mammary gland—breast cancer	0.000613	0.03	CbGeAlD
Dorzolamide—CA2—nipple—breast cancer	0.000599	0.0294	CbGeAlD
Dorzolamide—CA12—female reproductive system—breast cancer	0.000583	0.0286	CbGeAlD
Dorzolamide—CA5B—adipose tissue—breast cancer	0.000569	0.0279	CbGeAlD
Dorzolamide—CA5B—female reproductive system—breast cancer	0.000523	0.0257	CbGeAlD
Dorzolamide—CA5B—adrenal gland—breast cancer	0.000511	0.025	CbGeAlD
Dorzolamide—CA1—adipose tissue—breast cancer	0.000503	0.0247	CbGeAlD
Dorzolamide—CA2—embryo—breast cancer	0.000494	0.0242	CbGeAlD
Dorzolamide—CA12—endocrine gland—breast cancer	0.000494	0.0242	CbGeAlD
Dorzolamide—CA1—female reproductive system—breast cancer	0.000462	0.0227	CbGeAlD
Dorzolamide—CA5B—endocrine gland—breast cancer	0.000443	0.0217	CbGeAlD
Dorzolamide—CA1—bone marrow—breast cancer	0.000436	0.0214	CbGeAlD
Dorzolamide—CA2—epithelium—breast cancer	0.000403	0.0198	CbGeAlD
Dorzolamide—CA4—pituitary gland—breast cancer	0.000395	0.0194	CbGeAlD
Dorzolamide—CA4—adipose tissue—breast cancer	0.000393	0.0193	CbGeAlD
Dorzolamide—CA1—endocrine gland—breast cancer	0.000391	0.0192	CbGeAlD
Dorzolamide—CA2—skin of body—breast cancer	0.000384	0.0188	CbGeAlD
Dorzolamide—CA4—female reproductive system—breast cancer	0.000361	0.0177	CbGeAlD
Dorzolamide—CA4—adrenal gland—breast cancer	0.000353	0.0173	CbGeAlD
Dorzolamide—CA4—bone marrow—breast cancer	0.000341	0.0167	CbGeAlD
Dorzolamide—CA4—female gonad—breast cancer	0.000329	0.0161	CbGeAlD
Dorzolamide—CA2—pituitary gland—breast cancer	0.000327	0.016	CbGeAlD
Dorzolamide—CA2—adipose tissue—breast cancer	0.000326	0.016	CbGeAlD
Dorzolamide—CA5B—lymph node—breast cancer	0.000306	0.015	CbGeAlD
Dorzolamide—CA4—endocrine gland—breast cancer	0.000306	0.015	CbGeAlD
Dorzolamide—CA2—female reproductive system—breast cancer	0.0003	0.0147	CbGeAlD
Dorzolamide—CA2—adrenal gland—breast cancer	0.000292	0.0143	CbGeAlD
Dorzolamide—CA2—bone marrow—breast cancer	0.000283	0.0139	CbGeAlD
Dorzolamide—CA2—female gonad—breast cancer	0.000273	0.0134	CbGeAlD
Dorzolamide—CA1—lymph node—breast cancer	0.00027	0.0133	CbGeAlD
Dorzolamide—CA2—endocrine gland—breast cancer	0.000253	0.0124	CbGeAlD
Dorzolamide—CYP2C9—female reproductive system—breast cancer	0.000253	0.0124	CbGeAlD
Dorzolamide—CYP2C9—endocrine gland—breast cancer	0.000214	0.0105	CbGeAlD
Dorzolamide—CA4—lymph node—breast cancer	0.000211	0.0104	CbGeAlD
Dorzolamide—CYP3A4—female reproductive system—breast cancer	0.000193	0.00948	CbGeAlD
Dorzolamide—CA2—lymph node—breast cancer	0.000175	0.00859	CbGeAlD
Dorzolamide—CYP3A4—endocrine gland—breast cancer	0.000164	0.00802	CbGeAlD
Dorzolamide—Feeling abnormal—Paclitaxel—breast cancer	5.01e-05	0.000263	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5e-05	0.000262	CcSEcCtD
Dorzolamide—Oedema—Capecitabine—breast cancer	4.99e-05	0.000262	CcSEcCtD
Dorzolamide—Bradycardia—Epirubicin—breast cancer	4.98e-05	0.000261	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Paclitaxel—breast cancer	4.97e-05	0.000261	CcSEcCtD
Dorzolamide—Diarrhoea—Gemcitabine—breast cancer	4.97e-05	0.000261	CcSEcCtD
Dorzolamide—Erythema multiforme—Methotrexate—breast cancer	4.94e-05	0.000259	CcSEcCtD
Dorzolamide—Dizziness—Irinotecan—breast cancer	4.93e-05	0.000259	CcSEcCtD
Dorzolamide—Anorexia—Docetaxel—breast cancer	4.91e-05	0.000258	CcSEcCtD
Dorzolamide—Shock—Capecitabine—breast cancer	4.91e-05	0.000258	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—breast cancer	4.9e-05	0.000257	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—breast cancer	4.9e-05	0.000257	CcSEcCtD
Dorzolamide—Diarrhoea—Fluorouracil—breast cancer	4.88e-05	0.000256	CcSEcCtD
Dorzolamide—Tinnitus—Methotrexate—breast cancer	4.87e-05	0.000256	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—breast cancer	4.86e-05	0.000255	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—breast cancer	4.83e-05	0.000254	CcSEcCtD
Dorzolamide—Urticaria—Paclitaxel—breast cancer	4.83e-05	0.000253	CcSEcCtD
Dorzolamide—Hyperhidrosis—Capecitabine—breast cancer	4.82e-05	0.000253	CcSEcCtD
Dorzolamide—Hypotension—Docetaxel—breast cancer	4.82e-05	0.000253	CcSEcCtD
Dorzolamide—Body temperature increased—Paclitaxel—breast cancer	4.81e-05	0.000252	CcSEcCtD
Dorzolamide—Abdominal pain—Paclitaxel—breast cancer	4.81e-05	0.000252	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—breast cancer	4.76e-05	0.00025	CcSEcCtD
Dorzolamide—Anorexia—Capecitabine—breast cancer	4.76e-05	0.00025	CcSEcCtD
Dorzolamide—Vomiting—Irinotecan—breast cancer	4.74e-05	0.000249	CcSEcCtD
Dorzolamide—Vomiting—Mitoxantrone—breast cancer	4.74e-05	0.000249	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—breast cancer	4.73e-05	0.000248	CcSEcCtD
Dorzolamide—Dizziness—Fluorouracil—breast cancer	4.72e-05	0.000248	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—breast cancer	4.71e-05	0.000247	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—breast cancer	4.71e-05	0.000247	CcSEcCtD
Dorzolamide—Rash—Mitoxantrone—breast cancer	4.7e-05	0.000247	CcSEcCtD
Dorzolamide—Rash—Irinotecan—breast cancer	4.7e-05	0.000247	CcSEcCtD
Dorzolamide—Dermatitis—Irinotecan—breast cancer	4.7e-05	0.000246	CcSEcCtD
Dorzolamide—Dermatitis—Mitoxantrone—breast cancer	4.7e-05	0.000246	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Docetaxel—breast cancer	4.69e-05	0.000246	CcSEcCtD
Dorzolamide—Headache—Mitoxantrone—breast cancer	4.67e-05	0.000245	CcSEcCtD
Dorzolamide—Headache—Irinotecan—breast cancer	4.67e-05	0.000245	CcSEcCtD
Dorzolamide—Hypotension—Capecitabine—breast cancer	4.66e-05	0.000245	CcSEcCtD
Dorzolamide—Insomnia—Docetaxel—breast cancer	4.66e-05	0.000245	CcSEcCtD
Dorzolamide—Paraesthesia—Docetaxel—breast cancer	4.63e-05	0.000243	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—breast cancer	4.63e-05	0.000243	CcSEcCtD
Dorzolamide—Alopecia—Methotrexate—breast cancer	4.62e-05	0.000242	CcSEcCtD
Dorzolamide—Vomiting—Gemcitabine—breast cancer	4.62e-05	0.000242	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—breast cancer	4.61e-05	0.000242	CcSEcCtD
Dorzolamide—Dyspnoea—Docetaxel—breast cancer	4.59e-05	0.000241	CcSEcCtD
Dorzolamide—Somnolence—Docetaxel—breast cancer	4.58e-05	0.00024	CcSEcCtD
Dorzolamide—Rash—Gemcitabine—breast cancer	4.58e-05	0.00024	CcSEcCtD
Dorzolamide—Dermatitis—Gemcitabine—breast cancer	4.57e-05	0.00024	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—breast cancer	4.56e-05	0.000239	CcSEcCtD
Dorzolamide—Erythema—Methotrexate—breast cancer	4.55e-05	0.000239	CcSEcCtD
Dorzolamide—Headache—Gemcitabine—breast cancer	4.55e-05	0.000239	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Capecitabine—breast cancer	4.55e-05	0.000239	CcSEcCtD
Dorzolamide—Vomiting—Fluorouracil—breast cancer	4.54e-05	0.000238	CcSEcCtD
Dorzolamide—Dyspepsia—Docetaxel—breast cancer	4.54e-05	0.000238	CcSEcCtD
Dorzolamide—Insomnia—Capecitabine—breast cancer	4.51e-05	0.000237	CcSEcCtD
Dorzolamide—Rash—Fluorouracil—breast cancer	4.5e-05	0.000236	CcSEcCtD
Dorzolamide—Dermatitis—Fluorouracil—breast cancer	4.5e-05	0.000236	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—breast cancer	4.49e-05	0.000236	CcSEcCtD
Dorzolamide—Paraesthesia—Capecitabine—breast cancer	4.48e-05	0.000235	CcSEcCtD
Dorzolamide—Decreased appetite—Docetaxel—breast cancer	4.48e-05	0.000235	CcSEcCtD
Dorzolamide—Hypersensitivity—Paclitaxel—breast cancer	4.48e-05	0.000235	CcSEcCtD
Dorzolamide—Headache—Fluorouracil—breast cancer	4.47e-05	0.000235	CcSEcCtD
Dorzolamide—Dysgeusia—Methotrexate—breast cancer	4.46e-05	0.000234	CcSEcCtD
Dorzolamide—Dyspnoea—Capecitabine—breast cancer	4.45e-05	0.000233	CcSEcCtD
Dorzolamide—Fatigue—Docetaxel—breast cancer	4.44e-05	0.000233	CcSEcCtD
Dorzolamide—Nausea—Mitoxantrone—breast cancer	4.43e-05	0.000232	CcSEcCtD
Dorzolamide—Nausea—Irinotecan—breast cancer	4.43e-05	0.000232	CcSEcCtD
Dorzolamide—Pain—Docetaxel—breast cancer	4.41e-05	0.000231	CcSEcCtD
Dorzolamide—Back pain—Methotrexate—breast cancer	4.4e-05	0.000231	CcSEcCtD
Dorzolamide—Dyspepsia—Capecitabine—breast cancer	4.39e-05	0.00023	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—breast cancer	4.37e-05	0.000229	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—breast cancer	4.36e-05	0.000229	CcSEcCtD
Dorzolamide—Asthenia—Paclitaxel—breast cancer	4.36e-05	0.000229	CcSEcCtD
Dorzolamide—Decreased appetite—Capecitabine—breast cancer	4.34e-05	0.000228	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—breast cancer	4.32e-05	0.000227	CcSEcCtD
Dorzolamide—Nausea—Gemcitabine—breast cancer	4.31e-05	0.000226	CcSEcCtD
Dorzolamide—Fatigue—Capecitabine—breast cancer	4.3e-05	0.000226	CcSEcCtD
Dorzolamide—Pruritus—Paclitaxel—breast cancer	4.3e-05	0.000226	CcSEcCtD
Dorzolamide—Vision blurred—Methotrexate—breast cancer	4.29e-05	0.000225	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—breast cancer	4.28e-05	0.000225	CcSEcCtD
Dorzolamide—Pain—Capecitabine—breast cancer	4.27e-05	0.000224	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—breast cancer	4.26e-05	0.000224	CcSEcCtD
Dorzolamide—Feeling abnormal—Docetaxel—breast cancer	4.25e-05	0.000223	CcSEcCtD
Dorzolamide—Nausea—Fluorouracil—breast cancer	4.24e-05	0.000223	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—breast cancer	4.22e-05	0.000222	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Docetaxel—breast cancer	4.21e-05	0.000221	CcSEcCtD
Dorzolamide—Tension—Epirubicin—breast cancer	4.18e-05	0.000219	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—breast cancer	4.17e-05	0.000219	CcSEcCtD
Dorzolamide—Diarrhoea—Paclitaxel—breast cancer	4.16e-05	0.000218	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—breast cancer	4.14e-05	0.000217	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—breast cancer	4.12e-05	0.000216	CcSEcCtD
Dorzolamide—Feeling abnormal—Capecitabine—breast cancer	4.11e-05	0.000216	CcSEcCtD
Dorzolamide—Vertigo—Methotrexate—breast cancer	4.09e-05	0.000215	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Capecitabine—breast cancer	4.08e-05	0.000214	CcSEcCtD
Dorzolamide—Abdominal pain—Docetaxel—breast cancer	4.07e-05	0.000214	CcSEcCtD
Dorzolamide—Body temperature increased—Docetaxel—breast cancer	4.07e-05	0.000214	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—breast cancer	4.04e-05	0.000212	CcSEcCtD
Dorzolamide—Dizziness—Paclitaxel—breast cancer	4.02e-05	0.000211	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—breast cancer	4.01e-05	0.000211	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—breast cancer	4e-05	0.00021	CcSEcCtD
Dorzolamide—Cough—Methotrexate—breast cancer	3.97e-05	0.000208	CcSEcCtD
Dorzolamide—Urticaria—Capecitabine—breast cancer	3.96e-05	0.000208	CcSEcCtD
Dorzolamide—Abdominal pain—Capecitabine—breast cancer	3.94e-05	0.000207	CcSEcCtD
Dorzolamide—Body temperature increased—Capecitabine—breast cancer	3.94e-05	0.000207	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—breast cancer	3.94e-05	0.000207	CcSEcCtD
Dorzolamide—Arthralgia—Methotrexate—breast cancer	3.87e-05	0.000203	CcSEcCtD
Dorzolamide—Chest pain—Methotrexate—breast cancer	3.87e-05	0.000203	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—breast cancer	3.87e-05	0.000203	CcSEcCtD
Dorzolamide—Vomiting—Paclitaxel—breast cancer	3.87e-05	0.000203	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—breast cancer	3.86e-05	0.000203	CcSEcCtD
Dorzolamide—Rash—Paclitaxel—breast cancer	3.83e-05	0.000201	CcSEcCtD
Dorzolamide—Dermatitis—Paclitaxel—breast cancer	3.83e-05	0.000201	CcSEcCtD
Dorzolamide—Discomfort—Methotrexate—breast cancer	3.83e-05	0.000201	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—breast cancer	3.83e-05	0.000201	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—breast cancer	3.83e-05	0.000201	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—breast cancer	3.82e-05	0.0002	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—breast cancer	3.81e-05	0.0002	CcSEcCtD
Dorzolamide—Headache—Paclitaxel—breast cancer	3.81e-05	0.0002	CcSEcCtD
Dorzolamide—Hypersensitivity—Docetaxel—breast cancer	3.8e-05	0.000199	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—breast cancer	3.76e-05	0.000198	CcSEcCtD
Dorzolamide—Confusional state—Methotrexate—breast cancer	3.74e-05	0.000197	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—breast cancer	3.74e-05	0.000196	CcSEcCtD
Dorzolamide—Cough—Epirubicin—breast cancer	3.72e-05	0.000195	CcSEcCtD
Dorzolamide—Anaphylactic shock—Methotrexate—breast cancer	3.71e-05	0.000195	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—breast cancer	3.71e-05	0.000195	CcSEcCtD
Dorzolamide—Asthenia—Docetaxel—breast cancer	3.7e-05	0.000194	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—breast cancer	3.68e-05	0.000193	CcSEcCtD
Dorzolamide—Hypersensitivity—Capecitabine—breast cancer	3.68e-05	0.000193	CcSEcCtD
Dorzolamide—Pruritus—Docetaxel—breast cancer	3.65e-05	0.000191	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—breast cancer	3.63e-05	0.00019	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—breast cancer	3.63e-05	0.00019	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—breast cancer	3.61e-05	0.00019	CcSEcCtD
Dorzolamide—Nausea—Paclitaxel—breast cancer	3.61e-05	0.00019	CcSEcCtD
Dorzolamide—Hyperhidrosis—Methotrexate—breast cancer	3.59e-05	0.000188	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—breast cancer	3.58e-05	0.000188	CcSEcCtD
Dorzolamide—Asthenia—Capecitabine—breast cancer	3.58e-05	0.000188	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—breast cancer	3.55e-05	0.000186	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—breast cancer	3.54e-05	0.000186	CcSEcCtD
Dorzolamide—Anorexia—Methotrexate—breast cancer	3.54e-05	0.000186	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—breast cancer	3.53e-05	0.000185	CcSEcCtD
Dorzolamide—Pruritus—Capecitabine—breast cancer	3.53e-05	0.000185	CcSEcCtD
Dorzolamide—Diarrhoea—Docetaxel—breast cancer	3.53e-05	0.000185	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—breast cancer	3.5e-05	0.000184	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—breast cancer	3.48e-05	0.000183	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—breast cancer	3.48e-05	0.000182	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—breast cancer	3.48e-05	0.000182	CcSEcCtD
Dorzolamide—Hypotension—Methotrexate—breast cancer	3.47e-05	0.000182	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—breast cancer	3.46e-05	0.000182	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—breast cancer	3.44e-05	0.00018	CcSEcCtD
Dorzolamide—Shock—Epirubicin—breast cancer	3.42e-05	0.000179	CcSEcCtD
Dorzolamide—Diarrhoea—Capecitabine—breast cancer	3.41e-05	0.000179	CcSEcCtD
Dorzolamide—Dizziness—Docetaxel—breast cancer	3.41e-05	0.000179	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—breast cancer	3.4e-05	0.000179	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Methotrexate—breast cancer	3.38e-05	0.000178	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—breast cancer	3.36e-05	0.000176	CcSEcCtD
Dorzolamide—Insomnia—Methotrexate—breast cancer	3.36e-05	0.000176	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—breast cancer	3.35e-05	0.000176	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—breast cancer	3.35e-05	0.000176	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—breast cancer	3.34e-05	0.000175	CcSEcCtD
Dorzolamide—Paraesthesia—Methotrexate—breast cancer	3.33e-05	0.000175	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—breast cancer	3.31e-05	0.000174	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—breast cancer	3.31e-05	0.000174	CcSEcCtD
Dorzolamide—Dyspnoea—Methotrexate—breast cancer	3.31e-05	0.000174	CcSEcCtD
Dorzolamide—Somnolence—Methotrexate—breast cancer	3.3e-05	0.000173	CcSEcCtD
Dorzolamide—Dizziness—Capecitabine—breast cancer	3.3e-05	0.000173	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—breast cancer	3.28e-05	0.000172	CcSEcCtD
Dorzolamide—Vomiting—Docetaxel—breast cancer	3.28e-05	0.000172	CcSEcCtD
Dorzolamide—Dyspepsia—Methotrexate—breast cancer	3.27e-05	0.000172	CcSEcCtD
Dorzolamide—Rash—Docetaxel—breast cancer	3.25e-05	0.000171	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—breast cancer	3.25e-05	0.00017	CcSEcCtD
Dorzolamide—Dermatitis—Docetaxel—breast cancer	3.25e-05	0.00017	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—breast cancer	3.24e-05	0.00017	CcSEcCtD
Dorzolamide—Decreased appetite—Methotrexate—breast cancer	3.23e-05	0.000169	CcSEcCtD
Dorzolamide—Headache—Docetaxel—breast cancer	3.23e-05	0.000169	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—breast cancer	3.22e-05	0.000169	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—breast cancer	3.22e-05	0.000169	CcSEcCtD
Dorzolamide—Fatigue—Methotrexate—breast cancer	3.2e-05	0.000168	CcSEcCtD
Dorzolamide—Pain—Methotrexate—breast cancer	3.18e-05	0.000167	CcSEcCtD
Dorzolamide—Vomiting—Capecitabine—breast cancer	3.17e-05	0.000166	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—breast cancer	3.17e-05	0.000166	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—breast cancer	3.16e-05	0.000166	CcSEcCtD
Dorzolamide—Rash—Capecitabine—breast cancer	3.15e-05	0.000165	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—breast cancer	3.14e-05	0.000165	CcSEcCtD
Dorzolamide—Dermatitis—Capecitabine—breast cancer	3.14e-05	0.000165	CcSEcCtD
Dorzolamide—Headache—Capecitabine—breast cancer	3.13e-05	0.000164	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—breast cancer	3.12e-05	0.000164	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—breast cancer	3.11e-05	0.000163	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—breast cancer	3.1e-05	0.000163	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—breast cancer	3.09e-05	0.000162	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—breast cancer	3.07e-05	0.000161	CcSEcCtD
Dorzolamide—Nausea—Docetaxel—breast cancer	3.06e-05	0.000161	CcSEcCtD
Dorzolamide—Feeling abnormal—Methotrexate—breast cancer	3.06e-05	0.000161	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—breast cancer	3.06e-05	0.000161	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Methotrexate—breast cancer	3.04e-05	0.000159	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—breast cancer	3.02e-05	0.000159	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—breast cancer	3.01e-05	0.000158	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—breast cancer	3e-05	0.000157	CcSEcCtD
Dorzolamide—Pain—Epirubicin—breast cancer	2.97e-05	0.000156	CcSEcCtD
Dorzolamide—Nausea—Capecitabine—breast cancer	2.96e-05	0.000156	CcSEcCtD
Dorzolamide—Urticaria—Methotrexate—breast cancer	2.95e-05	0.000155	CcSEcCtD
Dorzolamide—Abdominal pain—Methotrexate—breast cancer	2.94e-05	0.000154	CcSEcCtD
Dorzolamide—Body temperature increased—Methotrexate—breast cancer	2.94e-05	0.000154	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.93e-05	0.000154	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—breast cancer	2.91e-05	0.000153	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—breast cancer	2.89e-05	0.000152	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—breast cancer	2.87e-05	0.00015	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—breast cancer	2.86e-05	0.00015	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—breast cancer	2.86e-05	0.00015	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—breast cancer	2.84e-05	0.000149	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—breast cancer	2.83e-05	0.000149	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—breast cancer	2.8e-05	0.000147	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—breast cancer	2.77e-05	0.000146	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—breast cancer	2.76e-05	0.000145	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—breast cancer	2.75e-05	0.000144	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—breast cancer	2.75e-05	0.000144	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—breast cancer	2.75e-05	0.000144	CcSEcCtD
Dorzolamide—Hypersensitivity—Methotrexate—breast cancer	2.74e-05	0.000144	CcSEcCtD
Dorzolamide—Asthenia—Methotrexate—breast cancer	2.66e-05	0.00014	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—breast cancer	2.65e-05	0.000139	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—breast cancer	2.63e-05	0.000138	CcSEcCtD
Dorzolamide—Pruritus—Methotrexate—breast cancer	2.63e-05	0.000138	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—breast cancer	2.56e-05	0.000134	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—breast cancer	2.55e-05	0.000134	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—breast cancer	2.54e-05	0.000133	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—breast cancer	2.54e-05	0.000133	CcSEcCtD
Dorzolamide—Diarrhoea—Methotrexate—breast cancer	2.54e-05	0.000133	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—breast cancer	2.49e-05	0.000131	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—breast cancer	2.46e-05	0.000129	CcSEcCtD
Dorzolamide—Dizziness—Methotrexate—breast cancer	2.46e-05	0.000129	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—breast cancer	2.38e-05	0.000125	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—breast cancer	2.37e-05	0.000124	CcSEcCtD
Dorzolamide—Vomiting—Methotrexate—breast cancer	2.36e-05	0.000124	CcSEcCtD
Dorzolamide—Rash—Methotrexate—breast cancer	2.34e-05	0.000123	CcSEcCtD
Dorzolamide—Dermatitis—Methotrexate—breast cancer	2.34e-05	0.000123	CcSEcCtD
Dorzolamide—Headache—Methotrexate—breast cancer	2.33e-05	0.000122	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—breast cancer	2.31e-05	0.000121	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—breast cancer	2.3e-05	0.000121	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—breast cancer	2.28e-05	0.000119	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—breast cancer	2.21e-05	0.000116	CcSEcCtD
Dorzolamide—Nausea—Methotrexate—breast cancer	2.21e-05	0.000116	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—breast cancer	2.2e-05	0.000115	CcSEcCtD
Dorzolamide—Rash—Epirubicin—breast cancer	2.19e-05	0.000115	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—breast cancer	2.19e-05	0.000115	CcSEcCtD
Dorzolamide—Headache—Epirubicin—breast cancer	2.18e-05	0.000114	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—breast cancer	2.13e-05	0.000112	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—breast cancer	2.06e-05	0.000108	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—breast cancer	2.04e-05	0.000107	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—breast cancer	2.03e-05	0.000106	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—breast cancer	2.03e-05	0.000106	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—breast cancer	2.01e-05	0.000106	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—breast cancer	1.91e-05	0.0001	CcSEcCtD
Dorzolamide—CA1—Metabolism—CAV1—breast cancer	1.13e-05	0.000147	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.13e-05	0.000146	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CG—breast cancer	1.12e-05	0.000146	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTEN—breast cancer	1.11e-05	0.000143	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—breast cancer	1.1e-05	0.000143	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—breast cancer	1.08e-05	0.00014	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CB—breast cancer	1.08e-05	0.00014	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTEN—breast cancer	1.08e-05	0.00014	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTEN—breast cancer	1.08e-05	0.00014	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CG—breast cancer	1.08e-05	0.00014	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—breast cancer	1.07e-05	0.000139	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CDA—breast cancer	1.06e-05	0.000137	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SHMT1—breast cancer	1.06e-05	0.000137	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	1.04e-05	0.000135	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CG—breast cancer	1.03e-05	0.000134	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.03e-05	0.000134	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLCO1B1—breast cancer	1.02e-05	0.000132	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC2A5—breast cancer	1.02e-05	0.000132	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTEN—breast cancer	1.01e-05	0.000131	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTEN—breast cancer	1.01e-05	0.000131	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CAV1—breast cancer	9.97e-06	0.000129	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	9.93e-06	0.000129	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CD—breast cancer	9.88e-06	0.000128	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APRT—breast cancer	9.81e-06	0.000127	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALB—breast cancer	9.75e-06	0.000126	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—breast cancer	9.63e-06	0.000125	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	9.59e-06	0.000124	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CD—breast cancer	9.47e-06	0.000123	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALB—breast cancer	9.35e-06	0.000121	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTEN—breast cancer	9.33e-06	0.000121	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NOS3—breast cancer	9.33e-06	0.000121	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ANGPTL4—breast cancer	9.22e-06	0.00012	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ESRRA—breast cancer	9.22e-06	0.00012	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SYNJ2—breast cancer	9.18e-06	0.000119	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CG—breast cancer	9.08e-06	0.000118	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CD—breast cancer	9.08e-06	0.000118	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALB—breast cancer	8.96e-06	0.000116	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NOS3—breast cancer	8.94e-06	0.000116	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	8.77e-06	0.000114	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HADHB—breast cancer	8.74e-06	0.000113	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPI—breast cancer	8.74e-06	0.000113	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CB—breast cancer	8.61e-06	0.000112	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NOS3—breast cancer	8.58e-06	0.000111	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NDUFS3—breast cancer	8.54e-06	0.000111	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—breast cancer	8.53e-06	0.000111	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	8.37e-06	0.000108	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDH1A1—breast cancer	8.34e-06	0.000108	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDH7A1—breast cancer	8.34e-06	0.000108	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CB—breast cancer	8.26e-06	0.000107	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	8.24e-06	0.000107	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—breast cancer	8.18e-06	0.000106	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CHST9—breast cancer	8.03e-06	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ADSL—breast cancer	8e-06	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PHGDH—breast cancer	8e-06	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UMPS—breast cancer	8e-06	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NME1—breast cancer	8e-06	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—FHL2—breast cancer	8e-06	0.000104	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CD—breast cancer	7.98e-06	0.000103	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CB—breast cancer	7.92e-06	0.000103	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALB—breast cancer	7.88e-06	0.000102	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—breast cancer	7.84e-06	0.000102	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HPSE—breast cancer	7.84e-06	0.000102	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—BRIP1—breast cancer	7.84e-06	0.000102	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LDHB—breast cancer	7.84e-06	0.000102	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CA—breast cancer	7.81e-06	0.000101	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CA—breast cancer	7.61e-06	9.86e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CA—breast cancer	7.61e-06	9.86e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—COX11—breast cancer	7.61e-06	9.86e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NOS3—breast cancer	7.54e-06	9.77e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTEN—breast cancer	7.44e-06	9.64e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA3—breast cancer	7.43e-06	9.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMMR—breast cancer	7.43e-06	9.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCC1—breast cancer	7.43e-06	9.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARGC1B—breast cancer	7.2e-06	9.33e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTEN—breast cancer	7.13e-06	9.25e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CA—breast cancer	7.11e-06	9.21e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CA—breast cancer	7.11e-06	9.21e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	7.01e-06	9.08e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	7.01e-06	9.08e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CB—breast cancer	6.96e-06	9.02e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SHMT1—breast cancer	6.96e-06	9.02e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CDA—breast cancer	6.96e-06	9.02e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—breast cancer	6.89e-06	8.94e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTEN—breast cancer	6.84e-06	8.86e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA4—breast cancer	6.8e-06	8.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA9—breast cancer	6.8e-06	8.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	6.71e-06	8.7e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC2A5—breast cancer	6.7e-06	8.68e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLCO1B1—breast cancer	6.7e-06	8.68e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	6.65e-06	8.61e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA2—breast cancer	6.63e-06	8.59e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX2—breast cancer	6.63e-06	8.59e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CA—breast cancer	6.58e-06	8.53e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX4—breast cancer	6.54e-06	8.48e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SULT1A1—breast cancer	6.54e-06	8.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APRT—breast cancer	6.47e-06	8.38e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA1—breast cancer	6.39e-06	8.28e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—IDH1—breast cancer	6.39e-06	8.28e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—breast cancer	6.38e-06	8.27e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NAT2—breast cancer	6.32e-06	8.19e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—breast cancer	6.22e-06	8.06e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—breast cancer	6.22e-06	8.06e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ESRRA—breast cancer	6.08e-06	7.88e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ANGPTL4—breast cancer	6.08e-06	7.88e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTEN—breast cancer	6.01e-06	7.79e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—breast cancer	5.8e-06	7.52e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—breast cancer	5.8e-06	7.52e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPI—breast cancer	5.77e-06	7.47e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HADHB—breast cancer	5.77e-06	7.47e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.71e-06	7.41e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—DPYD—breast cancer	5.54e-06	7.18e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MED12—breast cancer	5.54e-06	7.18e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.5e-06	7.13e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.5e-06	7.13e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDOA—breast cancer	5.46e-06	7.07e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—breast cancer	5.38e-06	6.97e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOA3—breast cancer	5.3e-06	6.86e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADSL—breast cancer	5.27e-06	6.83e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UMPS—breast cancer	5.27e-06	6.83e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—FHL2—breast cancer	5.27e-06	6.83e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PHGDH—breast cancer	5.27e-06	6.83e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NME1—breast cancer	5.27e-06	6.83e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC2A2—breast cancer	5.26e-06	6.82e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CA—breast cancer	5.25e-06	6.8e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.21e-06	6.75e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LDHB—breast cancer	5.17e-06	6.7e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HPSE—breast cancer	5.17e-06	6.7e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—BRIP1—breast cancer	5.17e-06	6.7e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CPT1A—breast cancer	5.15e-06	6.68e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTR—breast cancer	5.15e-06	6.68e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCG2—breast cancer	5.15e-06	6.68e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HPGDS—breast cancer	5.05e-06	6.55e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CA—breast cancer	5.03e-06	6.52e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HBA1—breast cancer	5.02e-06	6.51e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMMR—breast cancer	4.9e-06	6.35e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA3—breast cancer	4.9e-06	6.35e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCC1—breast cancer	4.9e-06	6.35e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTT1—breast cancer	4.9e-06	6.35e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACHE—breast cancer	4.9e-06	6.35e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CA—breast cancer	4.83e-06	6.25e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.75e-06	6.15e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP17A1—breast cancer	4.64e-06	6.01e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS1—breast cancer	4.59e-06	5.95e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ENO1—breast cancer	4.59e-06	5.95e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.58e-06	5.93e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.52e-06	5.85e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2D6—breast cancer	4.5e-06	5.84e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA9—breast cancer	4.48e-06	5.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA4—breast cancer	4.48e-06	5.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOA2—breast cancer	4.42e-06	5.73e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX2—breast cancer	4.37e-06	5.66e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA2—breast cancer	4.37e-06	5.66e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX4—breast cancer	4.32e-06	5.59e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SULT1A1—breast cancer	4.32e-06	5.59e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—breast cancer	4.29e-06	5.56e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—FASN—breast cancer	4.29e-06	5.56e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—BCHE—breast cancer	4.27e-06	5.53e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CA—breast cancer	4.24e-06	5.5e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC5A5—breast cancer	4.22e-06	5.47e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA1—breast cancer	4.22e-06	5.46e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—IDH1—breast cancer	4.22e-06	5.46e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NAT2—breast cancer	4.17e-06	5.4e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—breast cancer	4.11e-06	5.33e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NQO1—breast cancer	4.07e-06	5.28e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC2A1—breast cancer	4.07e-06	5.28e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.99e-06	5.17e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP3A4—breast cancer	3.97e-06	5.15e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.95e-06	5.12e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—breast cancer	3.94e-06	5.11e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1B1—breast cancer	3.91e-06	5.06e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.83e-06	4.96e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOA1—breast cancer	3.73e-06	4.83e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP19A1—breast cancer	3.67e-06	4.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—STK11—breast cancer	3.67e-06	4.76e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MED12—breast cancer	3.66e-06	4.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—DPYD—breast cancer	3.66e-06	4.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDOA—breast cancer	3.6e-06	4.66e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOA3—breast cancer	3.49e-06	4.53e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC2A2—breast cancer	3.47e-06	4.5e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—breast cancer	3.47e-06	4.49e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.45e-06	4.47e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—COMT—breast cancer	3.41e-06	4.42e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CPT1A—breast cancer	3.4e-06	4.4e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTR—breast cancer	3.4e-06	4.4e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCG2—breast cancer	3.4e-06	4.4e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTP1—breast cancer	3.4e-06	4.4e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMOX1—breast cancer	3.35e-06	4.34e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ITPR1—breast cancer	3.34e-06	4.33e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HPGDS—breast cancer	3.33e-06	4.32e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HBA1—breast cancer	3.31e-06	4.29e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACHE—breast cancer	3.23e-06	4.19e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTT1—breast cancer	3.23e-06	4.19e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCB1—breast cancer	3.22e-06	4.17e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TYMS—breast cancer	3.16e-06	4.09e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.12e-06	4.05e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOR1—breast cancer	3.12e-06	4.05e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—breast cancer	3.12e-06	4.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP17A1—breast cancer	3.06e-06	3.97e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ENO1—breast cancer	3.03e-06	3.93e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS1—breast cancer	3.03e-06	3.93e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX1—breast cancer	2.99e-06	3.87e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2D6—breast cancer	2.97e-06	3.85e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1A1—breast cancer	2.96e-06	3.84e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ERCC2—breast cancer	2.94e-06	3.8e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOA2—breast cancer	2.92e-06	3.78e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—FASN—breast cancer	2.83e-06	3.66e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—BCHE—breast cancer	2.82e-06	3.65e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC5A5—breast cancer	2.78e-06	3.6e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—breast cancer	2.76e-06	3.58e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC2A1—breast cancer	2.69e-06	3.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NQO1—breast cancer	2.69e-06	3.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1B1—breast cancer	2.58e-06	3.34e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CAV1—breast cancer	2.54e-06	3.3e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.53e-06	3.27e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOA1—breast cancer	2.46e-06	3.18e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.43e-06	3.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—STK11—breast cancer	2.42e-06	3.14e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP19A1—breast cancer	2.42e-06	3.14e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CG—breast cancer	2.32e-06	3e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—COMT—breast cancer	2.25e-06	2.92e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTP1—breast cancer	2.24e-06	2.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMOX1—breast cancer	2.21e-06	2.86e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ITPR1—breast cancer	2.2e-06	2.86e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCB1—breast cancer	2.12e-06	2.75e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TYMS—breast cancer	2.08e-06	2.7e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOR1—breast cancer	2.06e-06	2.67e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.06e-06	2.67e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—breast cancer	2.06e-06	2.67e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CD—breast cancer	2.04e-06	2.64e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALB—breast cancer	2.01e-06	2.61e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX1—breast cancer	1.97e-06	2.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1A1—breast cancer	1.95e-06	2.53e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ERCC2—breast cancer	1.94e-06	2.51e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NOS3—breast cancer	1.92e-06	2.49e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—breast cancer	1.82e-06	2.36e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CB—breast cancer	1.78e-06	2.3e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—breast cancer	1.76e-06	2.28e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CAV1—breast cancer	1.68e-06	2.18e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTEN—breast cancer	1.53e-06	1.99e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.53e-06	1.98e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.34e-06	1.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALB—breast cancer	1.33e-06	1.72e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NOS3—breast cancer	1.27e-06	1.64e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.17e-06	1.52e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—breast cancer	1.16e-06	1.5e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CA—breast cancer	1.08e-06	1.4e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTEN—breast cancer	1.01e-06	1.31e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—breast cancer	8.85e-07	1.15e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CA—breast cancer	7.14e-07	9.25e-06	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—breast cancer	5.83e-07	7.56e-06	CbGpPWpGaD
